https://www.dovepress.com/fibroblast-growth-factor-21-as-a-potential-therapeutic-target-of-nonal-peer-reviewed-fulltext-article-TCRM
The aim of this review is to critically summarize experimental and clinical data of fibroblast growth factor-21 in nonalcoholic fatty liver disease.
Create an account or login to join the discussion